Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 7, 2007

View Archived Issues

Micromet publishes two studies on its BiTE antibodies

Preclinical data on AV-101 indicate its potential for the treatment of PD

Targacept reports negative results from phase II clinical trial of TC-2696

Alpharma reports positive results from phase III trial of ALO-01 for pain relief

LifeCycle Pharma initiates phase II clinical trial of immunosuppressant LCP-Tacro

Novel therapeutic agents for neurological disorders reported in recent patents

Novel therapeutic agents for allergic and respiratory disorders disclosed in recent patents

4SC reports positive initial results from phase IIa clinical study of SC-12267 for RA

Recent Vitae patent discloses novel antihypertensive agents

OncoVista licenses OSI-7904L from OSI Pharmaceuticals

Arana Therapeutics provides an update on the clinical development plans for ART-621

Elan presents third quarter 2007 results

In vivo antimetastatic activity of novel irreversible uPA inhibitors

Mirodenafil significantly improves erectile dysfunction in double-blind study

Treatment effects and cardiovascular safety of dapoxetine assessed in phase III study

Rasagiline may slow deterioration of amyotrophic lateral sclerosis

Nippon Kayaku initiates phase II study of NK-105

Seikagaku initiates phase II study of SI-6603 for lumbar disc herniation

BioMarin enters research and option agreement with IGAN for IgA proteases

Eisai and BioArctic sign licensing agreement for BAN-2401 for Alzheimer's disease

NeuroSearch initiates phase I clinical study of NSD-644 for the treatment of pain

Bayer Schering Pharma takes next step towards important oral contraceptive milestone

Betaferon is only drug to delay disability in patients treated after first MS attack

Intercell's MAA for Japanese encephalitis vaccine is submitted to EMEA

E.U. approves Vectibix for the treatment of metastatic colorectal cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...